Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

× No keyword cloud information.

5 in total

1. Effects of 12-month valsartan therapy on glycation and oxidative stress markers in type 2 diabetic subjects with hypertension.

Authors: Naoko Komiya; Hiroshi Hirose; Yoshifumi Saisho; Ikuo Saito; Hiroshi Itoh
Journal: Int Heart J Date: 2008-11 Impact factor: 1.862

2. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

Authors: P J Beisswenger; S K Howell; A D Touchette; S Lal; B S Szwergold
Journal: Diabetes Date: 1999-01 Impact factor: 9.461

3. Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats.

Authors: Y Tanaka; H Uchino; T Shimizu; H Yoshii; M Niwa; C Ohmura; N Mitsuhashi; T Onuma; R Kawamori
Journal: Eur J Pharmacol Date: 1999-07-02 Impact factor: 4.432

4. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Authors: Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal: J Gastroenterol Date: 2010-01-30 Impact factor: 7.527

5. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

Authors: Austin Nelson; Dawn M Torres; Ana E Morgan; Christopher Fincke; Stephen A Harrison
Journal: J Clin Gastroenterol Date: 2009 Nov-Dec Impact factor: 3.062

5 in total